Report Detail
Global Ophthalmic Therapeutics/Drug Market Insights, Forecast to 2025
- RnM3109694 |
- 12 March, 2019 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
The global Ophthalmic Therapeutics/Drug market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Ophthalmic Therapeutics/Drug market based on company, product type, end user and key regions.
This report studies the global market size of Ophthalmic Therapeutics/Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Ophthalmic Therapeutics/Drug in these regions.
This research report categorizes the global Ophthalmic Therapeutics/Drug market by top players/brands, region, type and end user. This report also studies the global Ophthalmic Therapeutics/Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Alcon
Johnson and Johnson Vision Care, Inc.
Bausch & Lomb Incorporated
Novartis AG
Merck Sharp & Dohme Corp.
Regeneron Pharmaceuticals Inc.
Allergan
Pfizer Inc.
Valeant
Bayer AG
Santen Pharmaceuticals Co. Ltd
Genentech, Inc.
Market size by Product
Anti-allergy
Anti-VEGF Agents
Anti-inflammatory
Anti-glaucoma
Others
Market size by End User
Dry Eye
Allergies
Glaucoma
Infection
Retinal Disorders
Uveitis
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Ophthalmic Therapeutics/Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Ophthalmic Therapeutics/Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Ophthalmic Therapeutics/Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Ophthalmic Therapeutics/Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Ophthalmic Therapeutics/Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Ophthalmic Therapeutics/Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Ophthalmic Therapeutics/Drug Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Ophthalmic Therapeutics/Drug Market Size Growth Rate by Product
- 1.4.2 Anti-allergy
- 1.4.3 Anti-VEGF Agents
- 1.4.4 Anti-inflammatory
- 1.4.5 Anti-glaucoma
- 1.4.6 Others
- 1.5 Market by End User
- 1.5.1 Global Ophthalmic Therapeutics/Drug Market Size Growth Rate by End User
- 1.5.2 Dry Eye
- 1.5.3 Allergies
- 1.5.4 Glaucoma
- 1.5.5 Infection
- 1.5.6 Retinal Disorders
- 1.5.7 Uveitis
- 1.5.8 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Ophthalmic Therapeutics/Drug Market Size
- 2.1.1 Global Ophthalmic Therapeutics/Drug Revenue 2014-2025
- 2.1.2 Global Ophthalmic Therapeutics/Drug Sales 2014-2025
- 2.2 Ophthalmic Therapeutics/Drug Growth Rate by Regions
- 2.2.1 Global Ophthalmic Therapeutics/Drug Sales by Regions
- 2.2.2 Global Ophthalmic Therapeutics/Drug Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Ophthalmic Therapeutics/Drug Sales by Manufacturers
- 3.1.1 Ophthalmic Therapeutics/Drug Sales by Manufacturers
- 3.1.2 Ophthalmic Therapeutics/Drug Sales Market Share by Manufacturers
- 3.1.3 Global Ophthalmic Therapeutics/Drug Market Concentration Ratio (CR5 and HHI)
- 3.2 Ophthalmic Therapeutics/Drug Revenue by Manufacturers
- 3.2.1 Ophthalmic Therapeutics/Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 Ophthalmic Therapeutics/Drug Revenue Share by Manufacturers (2014-2019)
- 3.3 Ophthalmic Therapeutics/Drug Price by Manufacturers
- 3.4 Ophthalmic Therapeutics/Drug Manufacturing Base Distribution, Product Types
- 3.4.1 Ophthalmic Therapeutics/Drug Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Ophthalmic Therapeutics/Drug Product Type
- 3.4.3 Date of International Manufacturers Enter into Ophthalmic Therapeutics/Drug Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Ophthalmic Therapeutics/Drug Sales by Product
- 4.2 Global Ophthalmic Therapeutics/Drug Revenue by Product
- 4.3 Ophthalmic Therapeutics/Drug Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Ophthalmic Therapeutics/Drug Breakdown Data by End User
6 North America
- 6.1 North America Ophthalmic Therapeutics/Drug by Countries
- 6.1.1 North America Ophthalmic Therapeutics/Drug Sales by Countries
- 6.1.2 North America Ophthalmic Therapeutics/Drug Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Ophthalmic Therapeutics/Drug by Product
- 6.3 North America Ophthalmic Therapeutics/Drug by End User
7 Europe
- 7.1 Europe Ophthalmic Therapeutics/Drug by Countries
- 7.1.1 Europe Ophthalmic Therapeutics/Drug Sales by Countries
- 7.1.2 Europe Ophthalmic Therapeutics/Drug Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Ophthalmic Therapeutics/Drug by Product
- 7.3 Europe Ophthalmic Therapeutics/Drug by End User
8 Asia Pacific
- 8.1 Asia Pacific Ophthalmic Therapeutics/Drug by Countries
- 8.1.1 Asia Pacific Ophthalmic Therapeutics/Drug Sales by Countries
- 8.1.2 Asia Pacific Ophthalmic Therapeutics/Drug Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Ophthalmic Therapeutics/Drug by Product
- 8.3 Asia Pacific Ophthalmic Therapeutics/Drug by End User
9 Central & South America
- 9.1 Central & South America Ophthalmic Therapeutics/Drug by Countries
- 9.1.1 Central & South America Ophthalmic Therapeutics/Drug Sales by Countries
- 9.1.2 Central & South America Ophthalmic Therapeutics/Drug Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Ophthalmic Therapeutics/Drug by Product
- 9.3 Central & South America Ophthalmic Therapeutics/Drug by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Ophthalmic Therapeutics/Drug by Countries
- 10.1.1 Middle East and Africa Ophthalmic Therapeutics/Drug Sales by Countries
- 10.1.2 Middle East and Africa Ophthalmic Therapeutics/Drug Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Ophthalmic Therapeutics/Drug by Product
- 10.3 Middle East and Africa Ophthalmic Therapeutics/Drug by End User
11 Company Profiles
- 11.1 Alcon
- 11.1.1 Alcon Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Alcon Ophthalmic Therapeutics/Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Alcon Ophthalmic Therapeutics/Drug Products Offered
- 11.1.5 Alcon Recent Development
- 11.2 Johnson and Johnson Vision Care, Inc.
- 11.2.1 Johnson and Johnson Vision Care, Inc. Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Products Offered
- 11.2.5 Johnson and Johnson Vision Care, Inc. Recent Development
- 11.3 Bausch & Lomb Incorporated
- 11.3.1 Bausch & Lomb Incorporated Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Products Offered
- 11.3.5 Bausch & Lomb Incorporated Recent Development
- 11.4 Novartis AG
- 11.4.1 Novartis AG Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Novartis AG Ophthalmic Therapeutics/Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Novartis AG Ophthalmic Therapeutics/Drug Products Offered
- 11.4.5 Novartis AG Recent Development
- 11.5 Merck Sharp & Dohme Corp.
- 11.5.1 Merck Sharp & Dohme Corp. Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Products Offered
- 11.5.5 Merck Sharp & Dohme Corp. Recent Development
- 11.6 Regeneron Pharmaceuticals Inc.
- 11.6.1 Regeneron Pharmaceuticals Inc. Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Products Offered
- 11.6.5 Regeneron Pharmaceuticals Inc. Recent Development
- 11.7 Allergan
- 11.7.1 Allergan Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Allergan Ophthalmic Therapeutics/Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Allergan Ophthalmic Therapeutics/Drug Products Offered
- 11.7.5 Allergan Recent Development
- 11.8 Pfizer Inc.
- 11.8.1 Pfizer Inc. Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Pfizer Inc. Ophthalmic Therapeutics/Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Pfizer Inc. Ophthalmic Therapeutics/Drug Products Offered
- 11.8.5 Pfizer Inc. Recent Development
- 11.9 Valeant
- 11.9.1 Valeant Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Valeant Ophthalmic Therapeutics/Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Valeant Ophthalmic Therapeutics/Drug Products Offered
- 11.9.5 Valeant Recent Development
- 11.10 Bayer AG
- 11.10.1 Bayer AG Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Bayer AG Ophthalmic Therapeutics/Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Bayer AG Ophthalmic Therapeutics/Drug Products Offered
- 11.10.5 Bayer AG Recent Development
- 11.11 Santen Pharmaceuticals Co. Ltd
- 11.12 Genentech, Inc.
12 Future Forecast
- 12.1 Ophthalmic Therapeutics/Drug Market Forecast by Regions
- 12.1.1 Global Ophthalmic Therapeutics/Drug Sales Forecast by Regions 2019-2025
- 12.1.2 Global Ophthalmic Therapeutics/Drug Revenue Forecast by Regions 2019-2025
- 12.2 Ophthalmic Therapeutics/Drug Market Forecast by Product
- 12.2.1 Global Ophthalmic Therapeutics/Drug Sales Forecast by Product 2019-2025
- 12.2.2 Global Ophthalmic Therapeutics/Drug Revenue Forecast by Product 2019-2025
- 12.3 Ophthalmic Therapeutics/Drug Market Forecast by End User
- 12.4 North America Ophthalmic Therapeutics/Drug Forecast
- 12.5 Europe Ophthalmic Therapeutics/Drug Forecast
- 12.6 Asia Pacific Ophthalmic Therapeutics/Drug Forecast
- 12.7 Central & South America Ophthalmic Therapeutics/Drug Forecast
- 12.8 Middle East and Africa Ophthalmic Therapeutics/Drug Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Ophthalmic Therapeutics/Drug Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Ophthalmic Therapeutics/Drug. Industry analysis & Market Report on Ophthalmic Therapeutics/Drug is a syndicated market report, published as Global Ophthalmic Therapeutics/Drug Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Ophthalmic Therapeutics/Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
